|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 9/48 | (2006.01) |
| A61K 9/14 | (2006.01) | ||
| A61K 31/4184 | (2006.01) |
| (11) | Number of the document | 2367542 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09796303.7 |
| Date of filing the European patent application | 2009-12-03 | |
| (97) | Date of publication of the European application | 2011-09-28 |
| (45) | Date of publication and mention of the grant of the patent | 2014-01-01 |
| (46) | Date of publication of the claims translation | 2014-05-26 |
| (86) | Number | PCT/EP2009/008857 |
| Date | 2009-12-03 |
| (87) | Number | WO 2010/063493 |
| Date | 2010-06-10 |
| (30) | Number | Date | Country code |
| 08075915 | 2008-12-03 | EP |
| (72) |
COLLEDGE, Jeffrey, NL
OLTHOFF, Margaretha, NL
|
| (73) |
Astellas Deutschland GmbH,
Georg-Brauchle-Ring 64-66, 80992 München,
DE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Bendamustino peroralinės vaisto formos |
| ORAL DOSAGE FORMS OF BENDAMUSTINE |
| Payment date | Validity (years) | Amount | |
| 2022-11-22 | 14 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2023-12-03 |